Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Head and Neck Cancer

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 46 articles: HTML format

Single Articles

May 2024
1. MENG X, Zheng Y, Zhang L, Liu P, et al
   Single-cell analyses reveal the metabolic heterogeneity and plasticity of the tumor microenvironment during head and neck squamous cell carcinoma progression.
   Cancer Res. 2024 May 8. doi: 10.1158/0008-5472.CAN-23-1344.
   PubMed     Abstract available
   
   
   January 2024
2. LI C, Guo H, Zhai P, Yan M, et al
   Spatial and Single-Cell Transcriptomics Reveal a Cancer-Associated Fibroblast Subset in HNSCC That Restricts Infiltration and Antitumor Activity of CD8+ T Cells.
   Cancer Res. 2024;84:258-275.
   PubMed     Abstract available
   
   
   December 2023
3. SHI Q, Xu G, Jiang Y, Yang J, et al
   Phospholipase PLCE1 promotes transcription and phosphorylation of MCM7 to drive tumor progression in esophageal cancer.
   Cancer Res. 2023 Dec 20. doi: 10.1158/0008-5472.CAN-23-1633.
   PubMed     Abstract available
   
   
   October 2023
4. SMITH AE, Chan S, Wang Z, McCloskey A, et al
   Tipifarnib Potentiates the Antitumor Effects of PI3Kalpha Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity.
   Cancer Res. 2023;83:3252-3263.
   PubMed     Abstract available
   
   
   
5. LEE RH, Johnson DE, Grandis JR
   To Tip or Not to Tip: A New Combination for Precision Medicine in Head and Neck Cancer.
   Cancer Res. 2023;83:3162-3164.
   PubMed     Abstract available
   
   
   September 2023
6. SFANOS KS
   Intratumoral Bacteria as Mediators of Cancer Immunotherapy Response.
   Cancer Res. 2023;83:2985-2986.
   PubMed     Abstract available
   
   
   
7. ARBORE G, Albarello L, Bucci G, Punta M, et al
   Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma.
   Cancer Res. 2023;83:2873-2888.
   PubMed     Abstract available
   
   
   August 2023
8. WEED DT, Zilio S, McGee C, Marnissi B, et al
   The tumor immune microenvironment architecture correlates with risk of recurrence in head and neck squamous cell carcinoma.
   Cancer Res. 2023 Aug 21:CAN-23-0379. doi: 10.1158/0008-5472.CAN-23-0379.
   PubMed     Abstract available
   
   
   July 2023
9. WU H, Leng X, Liu Q, Mao T, et al
   Intratumoral Microbiota Composition Regulates Chemoimmunotherapy Response in Esophageal Squamous Cell Carcinoma.
   Cancer Res. 2023 Jul 11:CAN-22-2593. doi: 10.1158/0008-5472.CAN-22-2593.
   PubMed     Abstract available
   
   
   June 2023
10. CHEN C, Shin JH, Fang Z, Brennan K, et al
    Targeting KDM2A Enhances T Cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma.
    Cancer Res. 2023 Jun 13:CAN-22-3114. doi: 10.1158/0008-5472.CAN-22-3114.
    PubMed     Abstract available
    
    
    
11. SINGH PK, Mehla K
    LXR Signaling-Mediated Cholesterol Metabolism Reprogramming Regulates Cancer Cell Metastasis.
    Cancer Res. 2023;83:1759-1761.
    PubMed     Abstract available
    
    
    
12. BOREDDY SR, Nair R, Pandey PK, Kuriakose A, et al
    BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFbeta Signaling to Durably Suppress Tumor Growth.
    Cancer Res. 2023;83:1883-1904.
    PubMed     Abstract available
    
    
    May 2023
13. LI X, Wang C, Zhang H, Li Y, et al
    circFNDC3B Accelerates Vasculature Formation and Metastasis in Oral Squamous Cell Carcinoma.
    Cancer Res. 2023;83:1459-1475.
    PubMed     Abstract available
    
    
    February 2023
14. JAGADEESHAN S, Prasad M, Badarni M, Ben Lulu T, et al
    Mutated HRAS activates YAP1-AXL signaling to drive metastasis of head and neck cancer.
    Cancer Res. 2023 Feb 8:CAN-22-2586. doi: 10.1158/0008-5472.CAN-22-2586.
    PubMed     Abstract available
    
    
    
15. ZHANG GC, Yu XN, Guo HY, Sun JL, et al
    PRP19 Enhances Esophageal Squamous Cell Carcinoma Progression by Reprogramming SREBF1-Dependent Fatty Acid Metabolism.
    Cancer Res. 2023 Feb 1:OF1-OF17. doi: 10.1158/0008-5472.CAN-22-2156.
    PubMed     Abstract available
    
    
    January 2023
16. GUAN L, Nambiar DK, Cao H, Viswanathan V, et al
    NFE2L2 mutations enhance radioresistance in head and neck cancer by modulating intratumoral myeloid cells.
    Cancer Res. 2023 Jan 19:CAN-22-1903. doi: 10.1158/0008-5472.CAN-22-1903.
    PubMed     Abstract available
    
    
    December 2022
17. SHAH PA, Sambandam V, Fernandez AM, Zhao H, et al
    Sustained Aurora Kinase B Expression Confers Resistance to PI3K Inhibition in Head and Neck Squamous Cell Carcinoma.
    Cancer Res. 2022;82:4444-4456.
    PubMed     Abstract available
    
    
    November 2022
18. LIU Y, Kramer JR, Sandulache VC, Yu R, et al
    Immunogenetic Determinants of Susceptibility to Head and Neck Cancer in the Million Veteran Program Cohort.
    Cancer Res. 2022 Nov 15. pii: 710888. doi: 10.1158/0008-5472.CAN-22-1641.
    PubMed     Abstract available
    
    
    October 2022
19. LIU J, Liu ZX, Li JJ, Zeng ZL, et al
    The macrophage-associated lncRNA MALR facilitates ILF3 liquid-liquid phase separation to promote HIF1alpha signaling in esophageal cancer.
    Cancer Res. 2022 Oct 20. pii: 709866. doi: 10.1158/0008-5472.CAN-22-1922.
    PubMed     Abstract available
    
    
    September 2022
20. BRAND TM, Hartmann S, Bhola NE, Li H, et al
    Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
    Cancer Res. 2022;82:3187.
    PubMed    
    
    
    
21. BRAND TM, Hartmann S, Bhola NE, Li H, et al
    Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
    Cancer Res. 2022;82:3188.
    PubMed    
    
    
    August 2022
22. CHATURVEDI AK, Freedman ND, Abnet CC
    The Evolving Epidemiology of Oral Cavity and Oropharyngeal Cancers.
    Cancer Res. 2022;82:2821-2823.
    PubMed     Abstract available
    
    
    July 2022
23. LIU T, Zhao X, Lin Y, Luo Q, et al
    Computational Identification of Preneoplastic Cells Displaying High Stemness and Risk of Cancer Progression.
    Cancer Res. 2022;82:2520-2537.
    PubMed     Abstract available
    
    
    
24. LIAO L, He Y, Li SJ, Zhang GG, et al
    Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3.
    Cancer Res. 2022;82:2444-2457.
    PubMed     Abstract available
    
    
    June 2022
25. LI Y, Nie CJ, Hu L, Qin Y, et al
    Editor's Note: Characterization of a Novel Mechanism of Genomic Instability Involving the SEI1/SET/NM23H1 Pathway in Esophageal Cancers.
    Cancer Res. 2022;82:2197.
    PubMed    
    
    
    April 2022
26. LIN C, Song L, Gong H, Liu A, et al
    Editor's Note: Nkx2-8 Downregulation Promotes Angiogenesis and Activates NF-kappaB in Esophageal Cancer.
    Cancer Res. 2022;82:1670.
    PubMed    
    
    
    
27. LEE KK, Rishishwar L, Ban D, Nagar SD, et al
    Association of Genetic Ancestry and Molecular Signatures with Cancer Survival Disparities: A Pan-Cancer Analysis.
    Cancer Res. 2022;82:1222-1233.
    PubMed     Abstract available
    
    
    March 2022
28. DUAN X, Chen H, Zhou X, Liu P, et al
    EBV Infection in Epithelial Malignancies Induces Resistance to Antitumor Natural Killer Cells via F3-Mediated Platelet Aggregation.
    Cancer Res. 2022;82:1070-1083.
    PubMed     Abstract available
    
    
    
29. MOLKENTINE DP, Molkentine JM, Bridges KA, Valdecanas DR, et al
    p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade.
    Cancer Res. 2022;82:916-928.
    PubMed     Abstract available
    
    
    
30. YOU B, Xia T, Gu M, Zhang Z, et al
    AMPK-mTOR-Mediated Activation of Autophagy Promotes Formation of Dormant Polyploid Giant Cancer Cells.
    Cancer Res. 2022;82:846-858.
    PubMed     Abstract available
    
    
    October 2021
31. LIN A, Ji P, Niu X, Zhao X, et al
    CstF64-induced shortening of the BID 3'UTR promotes esophageal squamous cell carcinoma progression by disrupting ceRNA crosstalk with ZFP36L2.
    Cancer Res. 2021 Oct 4. pii: 0008-5472.CAN-21-1201.
    PubMed     Abstract available
    
    
    September 2021
32. STOSIC A, Fuligni F, Anderson ND, Davidson S, et al
    Diverse oncogenic fusions and distinct gene expression patterns define the genomic landscape of pediatric papillary thyroid carcinoma.
    Cancer Res. 2021 Sep 17. pii: 0008-5472.CAN-21-0761.
    PubMed     Abstract available
    
    
    
33. KIM J, Park B, Ha J, Steinberg I, et al
    Multiparametric Photoacoustic Analysis of Human Thyroid Cancers In Vivo.
    Cancer Res. 2021;81:4849-4860.
    PubMed     Abstract available
    
    
    August 2021
34. HIRATA H, Niida A, Kakiuchi N, Uchi R, et al
    The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy.
    Cancer Res. 2021 Aug 19. pii: 0008-5472.CAN-21-0653.
    PubMed     Abstract available
    
    
    July 2021
35. GE J, Wang J, Xiong F, Jiang X, et al
    Epstein-Barr virus-encoded circular RNA circBART2.2 promotes immune escape of nasopharyngeal carcinoma by regulating PD-L1.
    Cancer Res. 2021 Jul 28. pii: 0008-5472.CAN-20-4321.
    PubMed     Abstract available
    
    
    
36. MADABHUSHI A, Toro P, Willis JE
    Artificial Intelligence in Surveillance of Barrett's Esophagus.
    Cancer Res. 2021;81:3446-3448.
    PubMed     Abstract available
    
    
    June 2021
37. CHEN Z, Zhang C, Chen J, Wang D, et al
    The Proteomic Landscape of Growth Factor Signaling Networks Associated with FAT1 Mutations in Head and Neck Cancers.
    Cancer Res. 2021 Jun 24. pii: 0008-5472.CAN-20-3659.
    PubMed     Abstract available
    
    
    
38. WATERHOUSE DJ, Januszewicz W, Ali S, Fitzgerald RC, et al
    Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus.
    Cancer Res. 2021;81:3415-3425.
    PubMed     Abstract available
    
    
    
39. LIU SC, Tsang NM, Lee PJ, Sui YH, et al
    Epstein-Barr Virus Induces Adipocyte Dedifferentiation to Modulate the Tumor Microenvironment.
    Cancer Res. 2021;81:3283-3294.
    PubMed     Abstract available
    
    
    May 2021
40. LI Y, Wang M, Yang M, Xiao Y, et al
    Nicotine-induced ILF2 facilitates nuclear mRNA export of pluripotency factors to promote stemness and chemoresistance in human esophageal cancer.
    Cancer Res. 2021 May 11. pii: 0008-5472.CAN-20-4160.
    PubMed     Abstract available
    
    
    April 2021
41. SAULTERS E, Woolley JF, Varadarajan S, Jones TM, et al
    STINGing viral tumours: What we know from head and neck cancers.
    Cancer Res. 2021 Apr 26. pii: 0008-5472.CAN-21-0785.
    PubMed     Abstract available
    
    
    
42. ALVAREZ-TROTTA A, Guerrant W, Astudillo L, Lahiry M, et al
    Pharmacological disruption of the Notch1 transcriptional complex inhibits tumor growth by selectively targeting cancer stem cells.
    Cancer Res. 2021 Apr 5. pii: 0008-5472.CAN-20-3611.
    PubMed     Abstract available
    
    
    March 2021
43. MA S, Zhou B, Yang Q, Pan Y, et al
    A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal Adenocarcinoma.
    Cancer Res. 2021;81:1216-1229.
    PubMed     Abstract available
    
    
    February 2021
44. HUMTSOE JO, Kim HS, Leonard B, Ling S, et al
    Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL/AKT Axis in Salivary Adenoid Cystic Carcinoma.
    Cancer Res. 2021;81:1001-1013.
    PubMed     Abstract available
    
    
    
45. CURTIUS K, Dewanji A, Hazelton WD, Rubenstein JH, et al
    Optimal Timing for Cancer Screening and Adaptive Surveillance Using Mathematical Modeling.
    Cancer Res. 2021;81:1123-1134.
    PubMed     Abstract available
    
    
    January 2021
46. LIU J, Jiang X, Zou A, Mai Z, et al
    circIGHG-Induced Epithelial-to-Mesenchymal Transition Promotes Oral Squamous Cell Carcinoma Progression via miR-142-5p/IGF2BP3 Signaling.
    Cancer Res. 2021;81:344-355.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.